Market Place
Sourcing Support
All News #Library
Biotech
Amneal Pharma to buy Kashiv BioSciences in $1.1 billion deal
22 Apr 2026 //
REUTERS
Kashiv Biosecures Rs. 684 Crore To Expand Biopharma Facility
26 Dec 2025 //
INDPHARMAPOST
Kashiv Submits BLA To FDA, EMA Accepts ADL-018 Xolair Biosimilar
06 Oct 2025 //
PHARMAWEB
Kashiv Biosciences & JAMP Pharma Launch Pexegra & Filra in Canada
24 Sep 2025 //
PHARMIWEB
Kashiv Bio, CRISTÁLIA License Omalizumab Biosimilar ADL-018
11 Sep 2025 //
PHARMAWEB
Kashiv & MS Pharma Ink MENA License for XOLAIR Biosimilar ADL-018
05 Aug 2025 //
BUSINESSWIRE
Kashiv BioSciences Reports Positive Results for ADL-018 Study
25 Jun 2025 //
BUSINESSWIRE
Positive Results from Efficacy Study for Biosimilar to Xolair®
25 Jun 2025 //
GLOBENEWSWIRE
UK Agency Accepts Marketing Application for Biosimilar to Xolair
26 Mar 2025 //
GLOBENEWSWIRE
Kashiv Phase 1 Success For Abatacept Biosimilar Candidate KSHB002
28 Jan 2025 //
BUSINESSWIRE
Kashiv Licenses Proposed XOLAIR Biosimilar To Amneal
01 Jul 2024 //
BUSINESSWIRE
Kashiv BioSciences Enrolls First Patient in Phase III Clinical Study for ADL018
02 Oct 2023 //
BUSINESSWIRE
Kashiv Biosciences Announces Successful Phase 1 Study Results of ADL018
05 Jul 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.